diabetestalk.net

Abbott Diabetes Care Canada

Abbott Diabetes Care Division - Global Leader In Diabetes Care

Abbott Diabetes Care Division - Global Leader In Diabetes Care

WERE HELPING PEOPLE WITH DIABETES LEAD HEALTHIER, HAPPIER LIVES. As a global leader in diabetes care, Abbott is constantly working to deliver the highest quality products and unwavering support to our customers. Consistent and accurate glucose monitoring is the foundation of any diabetes management plan so were committed to continuous improvement in the way patients and professionals measure, track and analyze glucose levels. On the FreeStyle family of glucose monitoring systems to help them manage their diabetes. Depend on Abbott to provide them with state of the art tools to help them care for their patients with diabetes. WERE INNOVATING TODAY FOR A HEALTHIER TOMORROW Through a steadfast commitment to research, technology and state-of-the-art manufacturing, Abbott has developed a diverse portfolio of breakthrough diabetes products designed to meet the needs of each unique patient. Our innovative product development program is responsible for several groundbreaking technologies. Keep looking to our dedicated teams for the next generation of highly innovative and effective glucose monitoring products. We aim to set the standard for helping patients and healthcare providers to potentially achieve the best health outcomes. Continue reading >>

Abbott Freestyle Libre System Gets Health Canada License

Abbott Freestyle Libre System Gets Health Canada License

Abbott Freestyle Libre System Gets Health Canada License July 05, 2017, 09:09:00 AM EDT By Zacks Equity Research, Zacks.com Global medical device company Abbott Laboratories ABT has been constantly making efforts to expand its diabetes care business. The company recently announced the receipt of Health Canada license for its FreeStyleLibre Flash Glucose Monitoring System. This is a new glucose sensing technology for diabetic Canadian adults who do not need finger sticks for calibration and can scan current glucose levels anywhere and anytime. This first-of-its-kind system is available in 30 countries outside the U.S. making glucose monitoring more convenient and easier. The Freestyle Libre system reads glucose levels through a sensor that can be worn on the back of the upper arm hence eliminating the need for routine finger sticks. The scan shows real-time glucose results for a period of eight hours and the direction toward which the glucose level is headed. Also, the device provides the historical pattern of glucose levels over time by storing 90 days of data which further help doctors and patients better manage the disease. Two published clinical trials reveal that people who scan more frequently can better control and maintain glucose levels. They are also most likely to spend less time in hypoglycemia (low blood sugar) or hyperglycemia (high blood sugar). In this regard, we note that results from the IMPACT clinical trial demonstrated that diabetic patients using the FreeStyle Libre system spent 38% lesser time in hypoglycemia than people using with traditional self-monitoring of blood glucose systems (SMBG). The Freestyle Libre system is expected to be available inCanadasoon. According to a report by Allied Market Research , theglobal continuous glucose monitoring Continue reading >>

Abbott Diabetes Care Canada / Jim Pimblett, Consultant

Abbott Diabetes Care Canada / Jim Pimblett, Consultant

Abbott Diabetes Care Canada / Jim Pimblett, Consultant Lobbyist name: Jim Pimblett, Consultant Initial registration start date: 2016-07-15 Monthly communication reports in the last 6 months: 0 Version 1 of 2 (2016-07-15 to 2016-12-30) To introduce decision makers to Abbott Diabetes Care, and to discuss the role Abbott's technology can play in improving health outcomes for diabetes patients in indigenous communities The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking. No government funding was received during the last completed financial year. Yeesha Poon, Senior Manager, Market Access and Health Economics Abbott Diabetes Care Canada is not a coalition. Person or Organization with a Direct Interest Beneficiary Information The activities of Abbott Diabetes Care Canada are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking. Abbott Diabetes Care Canada does not have any subsidiaries that could have a direct interest in the outcome of the undertaking Continue reading >>

Diabetes Care Jobs In Mississauga, On (with Salaries) | Indeed.com

Diabetes Care Jobs In Mississauga, On (with Salaries) | Indeed.com

Canadian-owned and operated, offering services such as personal support, homemaking, respite care, palliative care, nursing, foot care and community clinics.... Coordinating care with the care coordinator, caregiver, hospital, interdisciplinary team, Primary Care Provider and other providers when required.... Specialized foot care. Home and community care nursing:. Home Care Nurse (HCN) - EXPANDED ROLE NURSES. Minimum of one-year recent related home and community... Canadian-owned and operated, offering services such as personal support, homemaking, respite care, palliative care, nursing, foot care and community clinics.... Define/redefines and communicates Care Services Strategy. This includes the Canadian Pharmacist Association, the Ontario Pharmacist Association, the Diabetes... Children with diabetes; Day care centre or nursery school; Salary$16.00HOUR hourly for 20 to 40 hours per week.... Certified Diabetes Educator (Required). Assesses, plans, implements and evaluates care for patients with diabetes individually and as a cohort.... Educate customers and patients regarding the importance of intensive diabetes management and continuous glucose monitoring for patients with diabetes.... Halton Diabetes Program. Membership in the Diabetes Educator Section of the Canadian Diabetes Association. Certified Diabetes Educator required.... Lead Retail Sales strategy for Abbott Diabetes Care Division (ADC) including both current BGM diabetes test strip business and launch of new FreeStyle Libre CGM... Individual Patient Care:. Certified Diabetes Educator (CDE) with the Canadian Diabetes Educator Certification Board (CDECB) required Excellent assessment,... Complex Care and Recovery Program. The Complex Care and Recovery Program is seeking an enthusiastic individual for a ful Continue reading >>

Abbott's New Freestyle Insulinx Blood Glucose Monitoring System With Insulin Calculator Now Available In Canada

Abbott's New Freestyle Insulinx Blood Glucose Monitoring System With Insulin Calculator Now Available In Canada

Abbott's New FreeStyle InsuLinx Blood Glucose Monitoring System with Insulin Calculator Now Available in Canada TORONTO, May 9, 2012 /PRNewswire via COMTEX/ --Device is the First Blood Glucose System in North America to Offer Mealtime Insulin Calculator Abbott today announced that its new FreeStyle InsuLinx Blood Glucose Monitoring System1 is now available in diabetes centres and select pharmacies across Canada. It is the first blood glucose monitoring device in North America that offers a mealtime insulin calculator for calculating suggested insulin doses. The FreeStyle InsuLinx System is designed to offer suggested insulin doses, as well as other features specifically intended to assist insulin-using patients in more effectively managing their diabetes. The user-friendly features include a touch screen interface, automated logbook, personalization preferences, and USB connectivity for plug-and-play reports. More than three million Canadians are living with diabetes2 and many of them require insulin to manage their condition. For those who use insulin, managing diabetes can often involve challenging calculations to determine an appropriate mealtime insulin dose. In a diabetes survey conducted in October 2011 by Leger Marketing, 200 Canadian healthcare professionals -- including general practitioners, diabetes nurse educators and endocrinologists -- stated that, in their respective clinics, four in ten mealtime insulin-using patients had difficulty calculating a mealtime insulin dose.3 Virtually all health care professionals (HCPs) surveyed (97%) believe that a patient's inability to manage insulin therapy limits the intensity and complexity of the therapy that an HCP can prescribe or recommend.4 "Insulin is a very important medication in the management of diabetes. Wh Continue reading >>

Abbott Wins Health Canada Nod For Freestyle Libre Glucose Monitor

Abbott Wins Health Canada Nod For Freestyle Libre Glucose Monitor

Home Abbott wins Health Canada nod for FreeStyle Libre glucose monitor Abbott wins Health Canada nod for FreeStyle Libre glucose monitor Abbott (NYSE: ABT ) said today that its FreeStyle Libre glucose monitoring system won Health Canada approval for adults with diabetes. The companys disposable glucose monitoring device is worn on the back of the upper arm and senses glucose using a small filament that is placed under the skin. Every scan includes a real-time glucose reading, as well as an 8-hour snapshot of blood sugar data. The reader contains up to 90 days of information, so users can study their glucose levels over time. Abbott said its system eliminates the need for routine finger sticks, which diabetic patients traditionally use to monitor their glucose levels. The 1st word that came to mind when I learned about FreeStyle Libre was freedom, Maria Miclea, who has Type I diabetes, said in a press release. Freedom from the pain of routine testing and from social awkwardness. Also, peace of mind, knowing that I can quickly and easily scan my glucose levels whenever and wherever I want to help better manage my diabetes. The company also said that its FreeStyle Libre system will be covered by 2 major Canadian insurers. At Abbott, our goal is to help people achieve their best health, Badia Boudaiffa, GM of Abbotts Canadian Diabetes Care business, said. Bringing FreeStyle Libre to the three million people living with diabetes across Canada is a major milestone.This technology not only transforms how people have been testing their glucose levels for decades, it also may support improved overall diabetes management. Only a Few More Days to Register for the most anticipated conference of the winter! DeviceTalks West is just a few days away. Join more than 300 of your peers Continue reading >>

Flash Glucose Monitoring System For Diabetes

Flash Glucose Monitoring System For Diabetes

Flash Glucose Monitoring System for Diabetes This report, originally posted in June 2017, has been updated to reflect the following changes, finalized in March of 2018: Statements were added regarding the methodology used to produce the report to improve transparency, including information on search time frames and the evidence synthesis approach. Updates to the presentation of evidence were made to provide more clarity, including information about study comparisons and conditions under which the technology was investigated. Appropriate attribution of report content to the professional and consumer versions of the device (FreeStyle Libre), where provided in the source articles, has been added. The changes do not include an updated literature search or inclusion of any further evidence that may have emerged since the original search-end date of February 10th, 2017. The consumer version of the FreeStyle Libre system intended for personal use by patients with diabetes received regulatory approval in Canada (June 2017) and the US (September 2017).1As of August 2017, the FreeStyle Libre system has been commercially available in Canada.2The report has not been updated to reflect these developments. FreeStyle Libre is a glucose monitoring system that uses a sensor implanted in the arm that a health care provider scans with a specialized reader for a record of glucose levels, trends, and patterns in people with diabetes. There are two versions of the technology a professional version (FreeStyle Libre Pro) and a consumer version (FreeStyle Libre). Studies on the FreeStyle Libre device have investigated its diagnostic test performance and accuracy, its clinical effectiveness (e.g., hypoglycemia, glycated hemoglobin, patient satisfaction, and safety), and its cost-effectiveness. Continue reading >>

Newsroom | Abbott Secures Health Canada License For Freestyle Libre System For People With Diabetes

Newsroom | Abbott Secures Health Canada License For Freestyle Libre System For People With Diabetes

ABBOTT SECURES HEALTH CANADA LICENSE FOR FREESTYLE LIBRE SYSTEM FOR PEOPLE WITH DIABETES REVOLUTIONARY SYSTEM ELIMINATES THE NEED FOR ROUTINE FINGER STICKS1 AND FINGER STICK CALIBRATION PROVIDES REAL-TIME GLUCOSE LEVELS FOR UP TO 14 DAYS WILL BE REIMBURSED BY TWO MAJOR CANADIAN INSURERS; AVAILABLE IN THE COMING MONTHS ACROSS CANADA ABBOTT PARK, Ill.,June 29, 2017/ PRNewswire / -- Abbott (NYSE: ABT) today announced the Health Canada license of its FreeStyleLibre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for Canadian adults with diabetes. The first-of-its-kind system eliminates the need for routine finger sticks,1requires no finger stick calibration, and reads glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days. "The first word that came to mind when I learned about FreeStyle Libre was 'freedom'," saidMaria Miclea, who has been managing her Type 1 diabetes for eight years. "Freedom from the pain of routine testing and from social awkwardness. Also, peace of mind, knowing that I can quickly and easily scan my glucose levels whenever and wherever I want to help better manage my diabetes." With traditional glucose monitoring systems, people with diabetes often have to stick their finger a number of times throughout the day2,3to test their glucose levels. With Abbott's FreeStyle Libre system, people now have a convenient, less painful alternative to get a glucose reading. The disposable sensor is worn on the back of the upper arm. The system measures glucose every minute in interstitial fluid through a small filament that is inserted just under the skin and held in place with a small adhesive pad. The sensor can read glucose levels through clothing,4making testing more convenient and discreet. Continue reading >>

Home | Abbott U.s.

Home | Abbott U.s.

You are about to exit for another Abbott country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions. The website you have requested also may not be optimized for your specific screen size. Do you wish to continue and exit this website? You are about to exit the Abbott family of websites for a 3rd party website Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimized for your screen size. Do you wish to continue and exit this website? Continue reading >>

Freestyle Libre System For People With Diabetes Available For Pre-order In Canada

Freestyle Libre System For People With Diabetes Available For Pre-order In Canada

FreeStyle Libre System for People with Diabetes Available for Pre-Order in Canada ABBOTT PARK, IL, Aug. 8, 2017 /CNW/ -Abbott today announced that its FreeStyle Libre Flash Glucose Monitoring System a revolutionary new glucose-sensing technology for Canadian adults with diabetes is now available for pre-order in Canada. The first-of-its-kind system, FreeStyle Libre eliminates the need for routine finger sticks,1 requires no finger stick calibration, and reads glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days. Abbott's Freestyle Libre system is now available for pre-order online only at MyFreeStyle.ca , at a cost of $49 for the reader, and $89 for each sensor (each sensor lasts for 14 days). With traditional blood glucose monitoring systems, people with diabetes have to stick their finger a number of times throughout the day1,2 to test their glucose levels. With Abbott's FreeStyle Libre system, Canadians with diabetes now have a convenient, less painful alternative to get a glucose reading. The disposable sensor is worn on the back of the upper arm. The system measures glucose every minute in interstitial fluid through a small filament that is inserted just under the skin and held in place with a small adhesive pad. The sensor can read glucose levels through clothing,3 making testing more convenient and discreet. Each scan displays a real-time glucose result, an eight-hour historical trend and the direction the glucose is heading. The reader holds up to 90 days of data, providing a historical snapshot of glucose levels over time. FreeStyle Libre system, which is being used by more than 300,000 people globally,4 is clinically proven to be accurate and consistent over a 14-day period, without the need for finger stick calibrat Continue reading >>

Abbott Diabetes Care Release: Freestyle Libre System For People With Diabetes Available For Pre-order In Canada

Abbott Diabetes Care Release: Freestyle Libre System For People With Diabetes Available For Pre-order In Canada

Abbott Diabetes Care Release: FreeStyle Libre System For People With Diabetes Available For Pre-Order In Canada ABBOTT PARK, IL, Aug. 8, 2017 /CNW/ -Abbott today announced that its FreeStyle Libre Flash Glucose Monitoring System a revolutionary new glucose-sensing technology for Canadian adults with diabetes is now available for pre-order in Canada. The first-of-its-kind system, FreeStyle Libre eliminates the need for routine finger sticks,1 requires no finger stick calibration, and reads glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days. Abbott's Freestyle Libre system is now available for pre-order online only at MyFreeStyle.ca , at a cost of $49 for the reader, and $89 for each sensor (each sensor lasts for 14 days). With traditional blood glucose monitoring systems, people with diabetes have to stick their finger a number of times throughout the day1,2 to test their glucose levels. With Abbott's FreeStyle Libre system, Canadians with diabetes now have a convenient, less painful alternative to get a glucose reading. The disposable sensor is worn on the back of the upper arm. The system measures glucose every minute in interstitial fluid through a small filament that is inserted just under the skin and held in place with a small adhesive pad. The sensor can read glucose levels through clothing,3 making testing more convenient and discreet. Each scan displays a real-time glucose result, an eight-hour historical trend and the direction the glucose is heading. The reader holds up to 90 days of data, providing a historical snapshot of glucose levels over time. FreeStyle Libre system, which is being used by more than 300,000 people globally,4 is clinically proven to be accurate and consistent over a 14-day period, without the Continue reading >>

Abbott Secures Health Canada License For Freestyle Libre System For People With Diabetes

Abbott Secures Health Canada License For Freestyle Libre System For People With Diabetes

Abbott Secures Health Canada License for FreeStyle Libre System for People with Diabetes - REVOLUTIONARY SYSTEM ELIMINATES THE NEED FOR ROUTINE FINGER STICKS1 AND FINGER STICK CALIBRATION - PROVIDES REAL-TIME GLUCOSE LEVELS FOR UP TO 14 DAYS - WILL BE REIMBURSED BY TWO MAJOR CANADIAN INSURERS; AVAILABLE IN THE COMING MONTHS ACROSS CANADA ABBOTT PARK, Ill., June 29, 2017 /PRNewswire/ -- Abbott (NYSE: ABT ) today announced the Health Canada license of its FreeStyle Libre Flash Glucose Monitoring System, a revolutionary new glucose sensing technology for Canadian adults with diabetes. The first-of-its-kind system eliminates the need for routine finger sticks,1 requires no finger stick calibration, and reads glucose levels through a sensor that can be worn on the back of the upper arm for up to 14 days. FreeStyle Libre system eliminates the need for routine finger sticks(1), requires no routine finger stick calibration, and reads glucose levels through a sensor worn on the back of the upper arm for up to 14 days. The disposable sensor, the size of a quarter, is worn on the back of the upper arm. The sensor can read glucose levels through clothing, making testing more convenient and discreet. FreeStyle Libre system eliminates the need for routine finger sticks(1), requires no routine finger stick calibration, and reads glucose levels through a sensor worn on the back of the upper arm for up to 14 days. The disposable sensor, the size of a quarter, is worn on the back of the upper arm. The sensor can read glucose levels through clothing, making testing more convenient and discreet. "The first word that came to mind when I learned about FreeStyle Libre was 'freedom'," said Maria Miclea, who has been managing her Type 1 diabetes for eight years. "Freedom from the pain of routi Continue reading >>

Abbott Laboratories - Wikipedia

Abbott Laboratories - Wikipedia

1888; 130years ago(1888) (as Abbott Alkaloidal Company) Abbott Laboratories is an American health care company with headquarters in Lake Bluff , Illinois , United States . The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; it eventually grew to also sell research-based drugs, medical devices, diagnostics, and nutritional products. It split off the research-based pharmaceuticals into Abbvie in 2013. In 2015, revenues were $20.4 billion. Abbott has a broad range of branded generic pharmaceuticals, medical devices, diagnostics, and nutrition products. The company's in-vitro diagnostics business performs immunoassays and blood screening. Its medical tests and diagnostic instrument systems are used worldwide by hospitals, laboratories, blood banks, and physician offices to diagnose and monitor diseases such as HIV, hepatitis, cancer, heart failure and metabolic disorders, as well as assess other indicators of health. In 1985, the company developed the first HIV blood-screening test. Abbott Point-of-Care manufactures diagnostic products for blood analysis to provide health care professionals diagnostics information at the point of patient care. Abbott also provides point-of-care cardiac assays to the emergency room. In 1888 at the age of 30, Wallace Abbott (18571921), an 1885 graduate of the University of Michigan , founded the Abbott Alkaloidal Company. At the time, he was a practicing physician and owned a drug store. His innovation was the use of the active part of a medicinal plant , generally an alkaloid (e.g., morphine , quinine , strychnine and codeine ), which he formed into tiny "dosimetric granules". This approach was successful since it produced more consistent and effective dosages for patients. [2] Abbott's first Continue reading >>

Abbott Diabetes Care Reviews

Abbott Diabetes Care Reviews

No much work (it's good for people to stay as much as they can) Act like a family business with ZERO ethics and compliance HR is bulling you when you ask for help or support Your line manager stalking you on social media posts and keep judging you in a very rude way! No career development (they working for money only with zero progress) The management always playing on emotional "acting " role to be appeared very kind in front of the Global team They have a rule "What happened in ADC Dubai stayed in ADC Dubai" ADC in the middle east is falling apart and I advise the global team to pay some attention to this and ignore their emotional drive and pretending they are angels because the ugly truth they are not! And check all complaints and the exit interviews for the HR , need a proper audit Flag as InappropriateFlag as Inappropriate The pay, particularly bonus and RSUs at the more senior levels. ADC has a horrible, bullying - even cruel - culture, where anyone who challenges authority, or is deemed to have contributed to an issue that prevents senior management from making bonus, is kicked out. Years of loyal service can suddenly mean nothing. A spineless HR function does nothing to stop this. There's a clique of senior managers who look to take the credit for everything and blame for nothing. In addition, the work is relentlessly tedious, driven by fire drills from senior management, and often low value add, and job cuts, to drive profit, have increased the workload to the extent a sensible work life balance is impossible. There's very little career development other than on the job training. Other than this, a great place to work. Continue reading >>

Abbott Freestyle Glucose Test Strips May Produce False Test Results With Certain Devices

Abbott Freestyle Glucose Test Strips May Produce False Test Results With Certain Devices

Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada , you can request alternate formats by contacting us . Abbott FreeStyle glucose test strips may produce false test results with certain devices Health Canada is informing Canadians that when Abbott FreeStyle glucose test strips are used with the devices listed below, there is a potential for users to receive a lower-than-actual blood sugar reading. False low blood sugar readings may lead to improper treatment decisions for users, such as increasing the consumption of sugar or not taking enough insulin, which in turn could lead to hyperglycemia (elevated blood sugar levels). The three devices are: Abbott Diabetes Cares FreeStyle Blood Glucose Meter and FreeStyle Mini Blood Glucose Meter, and Insulets OmniPod Insulin Management System. Consumers with the affected FreeStyle meters should contact Abbott Diabetes Care at 1-877-576-9368. Consumers with the Insulet OmniPod Insulin Management System should contact Abbott Diabetes Care at 1-877-607-6364 regarding the Freestyle strips, or if they have questions about the use of the system they should contact Insulet at 1-855-763-4636. The two companies are notifying customers to inform them of this issue. Consumers who have concerns related to the use of these devices should speak with their health care professional. Complaints involving medical devices can be reported to the Health Products and Food Branch Inspectorate by calling the toll-free hotline at 1-800-267-9675, or by writing to Continue reading >>

More in diabetes